CPA Calls on Trump Administration to Prioritize Metal Fabricators in Ongoing Trade Actions

CPA Calls on Trump Administration to Prioritize Metal Fabricators in Ongoing Trade Actions

To trade away aluminum and steel workers’ home market in exchange for padding Big Tech’s bottom line overseas is immoral and wrong. The Section 232 actions on aluminum and steel should be singularly focused on rebuilding domestic output across the supply chains, not used as leverage to help Google and Meta become even more profitable.

CPA Applauds Chairman Moolenaar for Advancing America First Investment Policy to Protect U.S. Capital and National Security

CPA Applauds Chairman Moolenaar for Advancing America First Investment Policy to Protect U.S. Capital and National Security

The America First Investment Policy rightly seeks to ensure that Wall Street can no longer channel hundreds of billions of U.S. dollars into companies that build China’s military, commit human rights atrocities, and threaten our national security. CPA strongly supports Chairman Moolenaar’s effort to codify this policy into law.

CPA Calls for Replacing USMCA with Two Bilateral Agreements to Restore U.S. Trade Sovereignty

CPA Calls for Replacing USMCA with Two Bilateral Agreements to Restore U.S. Trade Sovereignty

CPA’s submission, “Ensuring U.S. Sovereignty in North American Trade,” concludes that the current trilateral USMCA framework binds two vastly different economies to one unenforceable system—with each reliant on the far larger U.S. consumer market.

CPA Releases New Economics Report: “Section 232 Steel Tariffs Are Necessary For National Security”

CPA Releases New Economics Report: “Section 232 Steel Tariffs Are Necessary For National Security”

The report, titled “Section 232 Steel Tariffs are Necessary for National Security,” highlights how the Trump administration’s Section 232 tariffs have revitalized American manufacturing, created jobs, and strengthened national security.

Senate Witnesses Discuss Reshoring and Making China’s Massive Biotech Ecosystem Less Attractive for Big Pharma

Senate Witnesses Discuss Reshoring and Making China’s Massive Biotech Ecosystem Less Attractive for Big Pharma

Witnesses at a Senate hearing on Wednesday, Oct. 29 titled “The Future of Biotech” discussed ways to facilitate reshoring and making it attractive to expand in the U.S. and conduct R&D here instead of in China.

CPA Releases New Economics Report on America’s Chip-for-Chip Tariff Policy

CPA Releases New Economics Report on America’s Chip-for-Chip Tariff Policy

The report, titled “America’s Chip-for-Chip Tariff Policy: The Urgent Fight to Reclaim Industrial Independence Before It’s Too Late,” finds that the United States now produces only 10 percent of the world’s chips—and almost none of the most advanced ones—while China has captured the majority of global capacity for legacy chips, the mature semiconductors essential to cars, medical devices, and industrial equipment.